Related Experiment Video
Updated: Jan 4, 2026

Killer Artificial Antigen Presenting Cells KaAPC for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 11, 2014
Specific death of ALT cells through TSPYL5 depletion
Eloïse Claude1, Harikleia Episkopou1, Anabelle Decottignies1
1Genetic and Epigenetic Alterations of Genomes, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Abstract:
Some tumors acquire replicative immortality by activating an ALTernative telomerase-independent telomere maintenance mechanism. ALT offers interesting therapeutic perspectives but lacks any known specific targets. We discovered a crucial role for TSPYL5 (Testis-Specific Y-encoded-Like Protein 5) in keeping ALT cell viability by protecting POT1 (Protection Of Telomeres 1) from proteasomal degradation.
Insights
Testis-Specific Y-encoded-Like Protein 5 (TSPYL5) is crucial for maintaining the viability of Alternative Lengthening of Telomeres (ALT) cancer cells. TSPYL5 protects Protection Of Telomeres 1 (POT1) from degradation, offering potential new therapeutic targets for ALT-driven tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Alternative Lengthening of Telomeres (ALT) is a telomere maintenance mechanism enabling replicative immortality in some cancers.
- The ALT pathway bypasses telomerase, presenting unique therapeutic vulnerabilities.
- Currently, specific molecular targets for ALT-driven cancers remain largely unknown.
Purpose of the Study:
- To identify novel molecular targets within the ALT pathway.
- To investigate the role of TSPYL5 (Testis-Specific Y-encoded-Like Protein 5) in ALT-driven cancer cell viability.
- To elucidate the mechanism by which TSPYL5 influences telomere maintenance.
Main Methods:
- Analysis of TSPYL5 expression in ALT-positive cancer cells.
- Investigating the interaction between TSPYL5 and POT1 (Protection Of Telomeres 1).
- Assessing the impact of TSPYL5 modulation on cell viability and telomere length.
Main Results:
- TSPYL5 was found to be essential for the viability of ALT cells.
- TSPYL5 directly binds to and protects POT1 from proteasomal degradation.
- Inhibition of TSPYL5 leads to POT1 destabilization and impaired ALT function.
Conclusions:
- TSPYL5 plays a critical role in maintaining ALT cell survival by stabilizing POT1.
- TSPYL5 represents a potential therapeutic target for cancers utilizing the ALT pathway.
- Targeting TSPYL5 could offer a novel strategy to combat ALT-driven tumors.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Extrinsic Apoptotic Pathway
Replicative Cell Senescence
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

